Page 61 - Vitamin D and Cancer

48 J. Thorne and M.J. Campbell

102. Huss WJ, Gray DR, Werdin ES, Funkhouser WK Jr, Smith GJ (2004) Evidence of pluripotent
human prostate stem cells in a human prostate primary xenograft model. Prostate 60:77–90
103. Bikle DD, Gee E, Pillai S (1993) Regulation of keratinocyte growth, differentiation, and
vitamin D metabolism by analogs of 1, 25-dihydroxyvitamin D. J Invest Dermatol
101:713–718
104. Reichrath J et al (1994) Hair follicle expression of 1, 25-dihydroxyvitamin D3 receptors
during the murine hair cycle. Br J Dermatol 131:477–482
105. Sakai Y, Kishimoto J, Demay MB (2001) Metabolic and cellular analysis of alopecia in
vitamin D receptor knockout mice. J Clin Invest 107:961–966
106. Palmer HG, Martinez D, Carmeliet G, Watt FM (2008) The vitamin D receptor is required
for mouse hair cycle progression but not for maintenance of the epidermal stem cell compart-
ment. J Invest Dermatol 128:2113–2117
107. Ellison TI, Eckert RL, MacDonald PN (2007) Evidence for 1, 25-dihydroxyvitamin
D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and
ligand in keratinocytes. J Biol Chem 282:10953–10962
108. Nam Y et al (2006) A novel missense mutation in the mouse hairless gene causes irreversible
hair loss: genetic and molecular analyses of Hr m1Enu. Genomics 87:520–526
109. Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP (2006) Development and progression of
alopecia in the vitamin D receptor null mouse. J Cell Physiol 207:340–353
110. Beaudoin GM 3rd, Sisk JM, Coulombe PA, Thompson CC (2005) Hairless triggers reactivation
of hair growth by promoting Wnt signaling. Proc Natl Acad Sci USA 102:14653–14658
111. Thompson CC, Sisk JM, Beaudoin GM 3rd (2006) Hairless and Wnt signaling: allies in
epithelial stem cell differentiation. Cell Cycle 5:1913–1917
112. Palmer HG, Anjos-Afonso F, Carmeliet G, Takeda H, Watt FM (2008) The vitamin D recep-
tor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult
epidermis. PLoS ONE 3:e1483
113. Zinser G, Packman K, Welsh J (2002) Vitamin D(3) receptor ablation alters mammary gland
morphogenesis. Development 129:3067–3076
114. Zinser GM, Welsh J (2004) Accelerated mammary gland development during pregnancy and
delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol
18:2208–2223
115. Colston K, Colston MJ, Feldman D (1981) 1, 25-dihydroxyvitamin D3 and malignant mela-
noma: the presence of receptors and inhibition of cell growth in culture. Endocrinology
108:1083–1086
116. Miyaura C et al (1981) 1 alpha, 25-Dihydroxyvitamin D3 induces differentiation of human
myeloid leukemia cells. Biochem Biophys Res Commun 102:937–943
117. Abe E et al (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,
25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990–4994
118. Palmer HG et al (2003) Genetic signatures of differentiation induced by 1alpha, 25-dihy-
droxyvitamin D3 in human colon cancer cells. Cancer Res 63:7799–7806
119. Koike M et al (1997) 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent
inhibitors of proliferation of human breast cell lines. Cancer Res 57:4545–4550
120. Campbell MJ, Elstner E, Holden S, Uskokovic M, Koeffler HP (1997) Inhibition of prolif-
eration of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the
induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 19:15–27
121. Elstner E et al (1999) Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid
markedly inhibits colony growth of prostate cancer cells. Prostate 40:141–149
122. Peehl DM et al (1994) Antiproliferative effects of 1, 25-dihydroxyvitamin D3 on primary
cultures of human prostatic cells. Cancer Res 54:805–810
123. Welsh J et al (2002) Impact of the Vitamin D3 receptor on growth-regulatory pathways in
mammary gland and breast cancer. J Steroid Biochem Mol Biol 83:85–92
124. Colston KW, Berger U, Coombes RC (1989) Possible role for vitamin D in controlling breast
cancer cell proliferation. Lancet 1:188–191